Vice President, Information Technology
OtherHybridRockville3 weeks ago
Company identity and hiring signals verified from public source listings
Observed daily snapshots
Latest: 15 roles
Observed active listings increased from 4 to 15 across 12 snapshot days. Missing days are left as gaps and are not estimated.
| Date | Active listings |
|---|---|
| 2026-09-08 | 4 |
| 2026-09-09 | 4 |
| 2026-09-11 | 4 |
| 2026-09-13 | 4 |
| 2026-09-17 | 9 |
| 2026-09-30 | 13 |
| 2026-10-06 | 14 |
| 2026-10-12 | 15 |
| 2026-10-15 | 15 |
| 2026-10-18 | 15 |
| 2026-10-21 | 15 |
| 2026-10-24 | 15 |
Listing recency
Source observation shows when Base Career last saw listings at their source. It does not mean every listing was revalidated within the last 24 hours.
Based on n=15 classified listings
Based on n=15 classified listings
Based on n=15 classified listings
Based on n=15 classified listings
| Seniority | Median range | Sample |
|---|---|---|
| Senior | USD 170K–USD 230K / yearly | n=10 |
Verified active listings
OtherHybridRockville3 weeks ago
DataRemoteRemote1 months ago
OtherOnsiteRockvilleUSD 235K–USD 335K / yearly8 months ago
HealthcareRemoteUSAUSD 206K–USD 290K / yearly11 months ago
HealthcareFieldMaryland or Florida or Georgia or Virginia or South Carolina or North CarolinaUSD 170K–USD 230K / yearly
HrHybridRockville, Maryland, United StatesUSD 22–USD 24 / hourly
EngineeringFieldUnited States or Maryland or Massachusetts or New Jersey or New YorkUSD 170K–USD 230K / yearly
MarketingHybridRockville, Maryland, United StatesUSD 160K–USD 215K / yearly
HrOnsiteRockville, Maryland, United StatesUSD 149K–USD 212K / yearly
EngineeringRemoteUnited StatesUSD 160K–USD 218K / yearly
SalesFieldFlorida or Georgia or South Carolina or North AmericaUSD 187K–USD 265K / yearly
HealthcareRemoteUnited States
SoftwareRemoteVirginia or Maryland or United States
EngineeringOnsiteRockville, Maryland, United StatesUSD 235K–USD 335K / yearly
EngineeringFieldCalifornia or United StatesUSD 170K–USD 230K / yearly
Public clinical-stage biotechnology company developing one-time AAV gene therapies for rare, retinal, neuromuscular, and neurodegenerative diseases.